CTA Regulatory Guidelines and Compliance 1

Question 1

Which international guideline governs Good Clinical Practice (GCP)?

Accepted Answer

ICH E6(R2)

Answer

ICH E6(R2) is the internationally recognized guideline for Good Clinical Practice (GCP), developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. This guideline provides a unified standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. Adherence to ICH E6(R2) ensures the protection of human subjects and the credibility of data.

Question 2

What is the main purpose of FDA Form 1572?

Accepted Answer

To document investigator responsibilities

Answer

FDA Form 1572, also known as the Statement of Investigator, is a commitment form submitted to the FDA by the principal investigator (PI) of a clinical trial. By signing this form, the PI agrees to comply with FDA regulations, the investigational plan, and to ensure that all individuals assisting with the study are informed of their obligations. It formally documents the investigator's critical responsibilities in conducting the trial.

Question 3

What does 21 CFR Part 11 regulate?

Accepted Answer

Electronic records and signatures

Answer

21 CFR Part 11 is a regulation issued by the U.S. Food and Drug Administration (FDA) that sets forth the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It ensures the integrity, authenticity, and confidentiality of electronic data used in regulated industries, including clinical trials. This regulation is vital for the use of electronic systems in clinical research.

Question 4

Which regulatory body oversees drug approval in the United States?

Accepted Answer

FDA

Answer

The Food and Drug Administration (FDA) is the primary regulatory body in the United States responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. It reviews and approves new drugs before they can be marketed and sold to the public. The FDA's oversight is critical for consumer protection and drug development.

Question 5

What is a sponsor's key regulatory responsibility in a clinical trial?

Accepted Answer

Ensure protocol compliance and data reporting

Answer

The sponsor of a clinical trial holds ultimate responsibility for the initiation, management, and financing of the study. A key regulatory responsibility is to ensure that the trial is conducted in accordance with the approved protocol, Good Clinical Practice (GCP), and applicable regulations. This includes meticulous oversight of data collection, monitoring, and accurate and timely reporting to regulatory authorities.

(CTA) Clinical Trial Associate Certification Practice Test

(CTA) Clinical Trial Associate Certification Practice Test

CTA Regulatory Guidelines and Compliance 1